Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT02150655

Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women (RVMM)

Pilot Study Investigating Bacteria (Microbiota), Their By-products (Metabolome) and Environmental Toxins in Relation to Reproductive Health in Rwandan Women.

Sponsor: Western University, Canada

Conditions Bacterial Vaginosis Vulvovaginal Candidiasis

Interventions Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules Placebo

Updated 6 times since 2017 Last updated: May 29, 2014 Started: Sep 30, 2012 Primary completion: Sep 30, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Bacterial Vaginosis and Vulvovaginal Candidiasis and is currently completed. Western University, Canada leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Western University, Canada

Data source: Western University, Canada

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nyamata, Rwanda